Dr. Brandon Zipp is Director of Research and Development at Stevia First. Dr. Zipp was hired in December 2012 to expand the Company’s capabilities related to fermentation and plant sciences. Dr. Zipp obtained his PhD in Biochemistry and Molecular Biology from the University of California at Davis, and has performed work in secondary plant metabolism including studying of the glucosinolate biosynthetic pathway. He has diverse training and experience in biochemistry, molecular biology, and fermentation, combined with more than 10 years and hands-on laboratory experience working with plant UGTs, the special class of enzymes that produce sweet steviol glycosides within the Stevia leaf. His work at Stevia First has already led to notable deliverables including the filing of new intellectual property related to enzyme enhancement methods.

Recent Posts

Forward Looking Statements

This blog contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this blog which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, projections of worldwide sales of stevia products, growth of stevia production and global markets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this blog post, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this blog are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

This Blog is official and sanctioned by Stevia First Corp. | See Disclaimer | See Privacy Policy

Get Stevia First Corp. Blog Post Alerts